Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth

On August 26, 2026, Viva Biotech Holdings Group (the “Group” or the “Company,” stock code: 1873.HK) announced its financial results for the first half […]